Clinical Trial Update: Genetic Susceptibility to Cardiovascular Disease in Patients on Kidney Dialysis

View source ↗

Summary

A completed clinical trial assessing genetic factors that influence cardiovascular disease risk in patients with End-stage renal disease on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• End-stage Renal Disease

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: End Stage Renal Disease, ESRD | Status: COMPLETED